Cost analyses of positron emission tomography for clinical use
Costs associated with the clinical use of positron emission tomography (PET) at the Mallinckrodt Institute of Radiology are analyzed according to the two major components: radiopharmaceutical production and imaging. Estimated annual costs are $584,500 for PET radiopharmaceutical production and $644,250 for PET imaging (1982 US dollars). The economic break-even point charge to cover expenses is $615 to $2780 per clinical procedure, depending on several variables, especially procedure volume. Charges for PET clinical procedures will be among the highest of all charges for diagnostic imaging procedures, perhaps even higher than these estimates at some institutions. Several technologic and procedural approaches to reducing costs are suggested, the most promising being the anticipated availability of positron-emitting radionuclides from commercial suppliers.
- Research Organization:
- Washington Univ., St. Louis, MO
- OSTI ID:
- 5504701
- Journal Information:
- AJR, Am. J. Roentgenol.; (United States), Journal Name: AJR, Am. J. Roentgenol.; (United States) Vol. 141:5; ISSN AAJRD
- Country of Publication:
- United States
- Language:
- English
Similar Records
Positron Emission Tomography (PET)
Positron emission tomography and autoradiography
Related Subjects
62 RADIOLOGY AND NUCLEAR MEDICINE
ALKALI METAL ISOTOPES
BETA DECAY RADIOISOTOPES
BETA-PLUS DECAY RADIOISOTOPES
BODY
BRAIN
CARBON 11
CARBON ISOTOPES
CARDIOVASCULAR SYSTEM
CENTRAL NERVOUS SYSTEM
COMPUTERIZED TOMOGRAPHY
COST
DIAGNOSTIC TECHNIQUES
DIAGNOSTIC USES
DRUGS
ECONOMICS
ELECTRON CAPTURE RADIOISOTOPES
EMISSION COMPUTED TOMOGRAPHY
EVEN-ODD NUCLEI
FLUORINE 18
FLUORINE ISOTOPES
HEART
HOURS LIVING RADIOISOTOPES
INTERMEDIATE MASS NUCLEI
ISOTOPES
LABELLED COMPOUNDS
LIGHT NUCLEI
MINUTES LIVING RADIOISOTOPES
MUSCLES
MYOCARDIUM
NERVOUS SYSTEM
NUCLEI
ODD-ODD NUCLEI
ORGANS
PATIENTS
POSITRON COMPUTED TOMOGRAPHY
RADIOISOTOPES
RADIOPHARMACEUTICALS
RUBIDIUM 82
RUBIDIUM ISOTOPES
TOMOGRAPHY
USES